Trials / Completed

CompletedNCT02823743

RECAB-ASA; Treatment of Recurrent Abortion With Aspirin

Treatment of Recurrent Abortion With Low Dose Aspirin - a Randomized Placebo Controlled Trial

Status: Completed
Phase: N/A
Study type: Interventional
Enrollment: 400 (actual)

Sponsor: Göteborg University · Academic / Other
Sex: Female
Age: 39 Years
Healthy volunteers: Not accepted

Summary

The aim of this study is to examine whether treatment with 75 mg aspirin daily compared with placebo could reduce the risk for a new miscarriage. The treatment starts when the pregnancy is detected on transvaginal ultrasound (around gestational week 6+) and continues to week 35/36. The study is a single center, randomized, placebo-controlled, double blind and stratified for age. 400 participants with the diagnosis idiopathic recurrent abortion are enrolled, 200 in each arm aspirin / placebo.

Conditions

Abortion, Habitual

Interventions

Type	Name	Description
DRUG	Aspirin	Daily medication
DRUG	Placebo	Daily intake

Timeline

Start date: 2008-03-01
Primary completion: 2016-04-01
Completion: 2016-06-01
First posted: 2016-07-06
Last updated: 2016-07-06

Source: ClinicalTrials.gov record NCT02823743. Inclusion in this directory is not an endorsement.